Last Updated: May 12, 2026

Drugs Containing Excipient (Inactive Ingredient) DIBASIC CALCIUM PHOSPHATE DIHYDRATE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE excipient

Market Dynamics and Financial Trajectory for DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Last updated: March 31, 2026

What Is DIBASIC CALCIUM PHOSPHATE DIHYDRATE?

Dibasic calcium phosphate dihydrate (DCPD), also known as "brushite," is a calcium phosphate salt. It is used primarily as a pharmaceutical excipient, a dietary supplement, and in dental and orthopedic applications. It functions as a filler, stabilizer, and active ingredient in various formulations.

What Are Key Drivers of Market Growth?

Expanding Pharmaceutical Sector

The increase in global pharmaceutical R&D expenditure supports growing demand for excipients like DCPD. The global pharma market is projected to grow from USD 1.6 trillion in 2021 to USD 2.4 trillion by 2027, at a CAGR of 7.2% (source: Statista[1]).

Rising Use in Dietary Supplements

DCPD's calcium content makes it a preferred calcium source in supplements. The global dietary supplement market reached USD 140 billion in 2021 with a CAGR of 8.9% (source: Grand View Research[2]). Growing awareness about bone health and aging populations sustain demand.

Dental and Orthopedic Applications

DCPD's biocompatibility and bioresorbability suit it for bone grafts and dental restorative materials. The medical ceramics market is expected to grow at approximately 6.5% annually through 2027 (source: MarketsandMarkets[3]).

Regulatory Approvals and Safety Profile

Authorization by agencies like the FDA and EMA as Generally Recognized As Safe (GRAS) compounds supports market expansion.

What Are Market Constraints?

Supply Chain Complexity

DCPD production involves phosphate rock mining, chemical synthesis, and purification processes sensitive to geopolitical and environmental factors. Disruptions can impact availability and pricing.

Competition from Alternative Excipients

Other calcium salts such as calcium carbonate and calcium citrate are cheaper and more widely available. Their lower cost constrains DCPD's market share.

Regulatory Challenges

Differing standards for pharmaceutical and food-grade materials limit cross-application scalability. Increased regulation can delay product approval and increase costs.

What Are Major Market Segments?

Segment Description Growth Rate Key Applications
Pharmaceutical Excipient Fillers, stabilizers ~5.5% CAGR (2022–2028) Tablets, capsules
Dietary Supplements Calcium source 8.9% CAGR (2021–2028) Bone health, osteoporosis
Dental & Orthopedic Bone grafts, implants 6.5% CAGR (2022–2027) Bone regeneration

Who Are Leading Players and Their Strategies?

Top Producers

  • DST Pharma: Focuses on high-purity grades, expanding capacity.
  • GSP Crop Science: Emphasizes vertical integration from raw material sourcing.
  • Sigma-Aldrich (Merck): Offers a broad range of excipient grades, investing in R&D for specialized applications.

Strategic Moves

  • Investing in sustainable mining practices to secure raw material supply.
  • Developing customized grades for niche medical applications.
  • Forming partnerships with healthcare companies for joint development.

What Are Financial Trends and Projections?

Industry Revenue and Pricing

The global DCPD market was estimated at USD 150 million in 2022. A compounded annual growth rate of 6–8% is projected through 2030. Prices vary based on purity, form, and application, ranging from USD 10 to USD 35 per kg.

Investment Outlook

Major capital expenditures are underway to boost production capacities, driven by demand forecasts and regulatory approvals. The trend toward bio-based and sustainable excipient production is gaining traction, influenced by environmental policies.

Regional Market Differentiation

  • North America accounts for approximately 40% of sales, driven by pharmaceutical R&D.
  • Asia-Pacific shows rapid growth due to expanding pharmaceutical manufacturing and raw material availability.
  • Europe maintains significant market share, emphasizing regulated quality standards.

What Are Future Market Trends?

  • Increasing adoption in regenerative medicine and biomaterials.
  • Development of cost-effective synthesis methods to reduce prices.
  • Regulatory frameworks standardizing excipient specifications across regions.
  • Integration of digital supply chain management to mitigate disruptions.

Key Takeaways

  • The DCPD market relies heavily on the expanding pharmaceutical, dental, and dietary supplement sectors.
  • Supply chain stability and competition from alternative calcium salts define growth constraints.
  • Market players invest in capacity expansion, sustainable sourcing, and product customization.
  • Revenue growth averages 6–8% annually, with regional variations based on regulatory and industrial factors.
  • Future growth hinges on technological innovations and regulatory standardizations.

FAQs

1. How does DCPD compare to other calcium phosphate excipients?

DCPD has a higher bioresorption rate and is more bioactive than calcium carbonate, making it suitable for bone regeneration. Its manufacturing costs are higher, which affects its price competitiveness.

2. What are the primary regulatory challenges faced by DCPD manufacturers?

Manufacturers must adhere to strict quality standards such as USP, EP, and Ph. Eur., and obtain approvals for specific applications. Regulatory delays can limit market entry.

3. Which regions offer the most growth opportunities for DCPD?

Asia-Pacific presents rapid growth potential due to expanding pharmaceutical manufacturing and raw material availability. North America remains dominant due to high research and development activity.

4. Are there sustainability concerns associated with DCPD production?

Yes. The reliance on phosphate rock mining raises environmental concerns. Companies are exploring greener extraction methods and recycled raw materials to address sustainability issues.

5. What technological innovations are shaping the future of DCPD?

Advances include low-temperature synthesis processes, functionalized grades for targeted applications, and integration with bioactive scaffolds for medical use.

References

  1. Statista. (2023). Global pharmaceutical market size 2021-2027. Retrieved from https://www.statista.com
  2. Grand View Research. (2022). Dietary supplement market size & trends. Retrieved from https://www.grandviewresearch.com
  3. MarketsandMarkets. (2022). Medical ceramics market forecast. Retrieved from https://www.marketsandmarkets.com

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.